• SARS-CoV-2 NSP15 Screening Identifies Two Natural Leads

  2026-09-25

  A structure-based screen of natural products prioritized thymopentin and oleuropein as candidate binders of the SARS-CoV-2 NSP15 endoribonuclease, with molecular-dynamics simulations indicating stable modeled complexes. The study offers a computational starting point for inhibitor validation, not experimental proof of antiviral activity.

• Tiamulin: From Ribosome Binding to Translational Insight

  2026-09-25

  Tiamulin (Thiamutilin) offers a useful case study in how ribosomal target engagement, resistance biology, exposure, and host inflammatory readouts can shape translational research. This article connects pleuromutilin mechanism to practical assay design while distinguishing veterinary evidence from early, exploratory anti-inflammatory research.

• Pentoxifylline in Leishmaniasis and HTLV-1 Pathology

  2026-09-24

  A 2008 review connects TNF-α-driven immunopathology in leishmaniasis and HTLV-1-associated myelopathy with evidence that Pentoxifylline can suppress inflammatory T-cell responses. Its synthesis of patient-cell, serum, and clinical-study findings supports further evaluation of this phosphodiesterase inhibitor as an immunomodulatory approach, while leaving important questions about efficacy and treatment protocols unresolved.

• Forskolin and cAMP Control of Neuronal Calcium Signals

  2026-09-24

  Forskolin is an adenylate cyclase activator that offers a useful way to probe cAMP-dependent control of neuronal calcium signaling. This article examines how a 2024 hippocampal-neuron study used forskolin to test a rapid glucocorticoid mechanism—and what that result does, and does not, establish for assay design.

• Carvacrol Workflows for TRP and Redox Research

  2026-09-23

  Use Carvacrol as a non-electrophilic TRPA1 agonist to test how oxidative modification changes channel responses, while keeping singlet-oxygen and hydrogen-peroxide experiments analytically distinct. This practical guide connects calcium-imaging workflows with separate cell-cycle and apoptosis assays—and highlights controls that help prevent solvent, light, and viability effects from confounding results.

• Indometacin Sodium: From COX to Repair Biology

  2026-09-23

  Indometacin Sodium is more than a conventional COX inhibitor: its prostaglandin biology, reported Wnt/β-catenin activity, and potential role in oligodendrocyte differentiation create a translational opportunity—provided researchers separate mechanism, formulation, and safety signals with disciplined experimental design.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-09-22

  The reference study shows that dietary arachidonic acid can enhance rabies vaccine-induced neutralizing antibodies and improve protection in mice, while accelerating protective antibody development in human volunteers. Its mechanistic contribution is the identification of a lymph-node ARA–PGI2–cAMP/PKA pathway that promotes CD86 expression and AID activity, linking lipid metabolism to germinal-center B-cell function.

• Radioiodinated Balsalazide for UC Imaging in Mice

  2026-09-22

  The reference study developed and evaluated radioiodinated balsalazide as a colon-targeted tracer for ulcerative colitis in mice. Its optimized labeling conditions, 24-hour stability, and markedly higher uptake in inflamed colon tissue provide a practical preclinical framework for imaging-centered inflammation research, while also highlighting important limits for translation to human diagnostics.

• BRD4 Inhibition Enhances Erastin Ferroptosis

  2026-09-21

  A 2024 Discover Oncology study shows that pharmacological or genetic BRD4 inhibition sensitizes multiple cell lines to erastin-induced ferroptosis. The work identifies reactive oxygen species accumulation and reduced FSP1 expression as shared mechanistic features, supporting rational combinations of BET inhibitors with ferroptosis-inducing strategies in cancer biology research.

• KR-12: From Membrane Biology to Assay Design

  2026-09-21

  KR-12 human antimicrobial peptide research is most informative when formulation, membrane mechanism, microbial phenotype, and host-response assays are interpreted together. This guide develops a decision-centered framework for using KR-12 (human) TFA in antimicrobial, biofilm, and translational studies.

• TPPU: Soluble Epoxide Hydrolase Inhibitor Workflows

  2026-09-20

  TPPU enables nanomolar sEH modulation across lipidomics, osteoclastogenesis, and inflammatory pain workflows. This practical guide connects fatty acid epoxide signaling with liver–bone research while emphasizing solvent control, paired EET/DHET measurements, and assay-specific troubleshooting.

• Metoprolol for Reliable Cell Assays

  2026-09-19

  Learn how Metoprolol (SKU BA2737) can support interpretable cell viability, proliferation, and cytotoxicity workflows through controlled beta1-adrenergic signaling. This scenario-based guide covers assay compatibility, titration, disease-state interpretation, and practical product selection.

• a-MSH, amide: Reliable Assay Workflows

  2026-09-18

  Learn how a-MSH, amide (SKU A1025) can support reproducible pigmentation, viability, proliferation, and receptor-pharmacology experiments. This scenario-based guide covers peptide handling, vehicle compatibility, protocol optimization, data interpretation, and practical vendor-selection criteria.

• WDR36 and Cytokine-Aware Embryo Models

  2026-09-18

  A translational framework connecting WDR36-driven glycolytic control of trophectoderm differentiation with carefully controlled cytokine perturbation using Recombinant Human IL-6, Tag Free.

• Honokiol Workflows for NF-κB and T-Cell Research

  2026-09-17

  Honokiol offers a practical way to interrogate inflammatory signaling, oxidative stress, tumor-cell responses, and angiogenesis in coordinated assay designs. This workflow also shows how to place Honokiol beside, rather than overstate it as a regulator of, the CD28-ARS2-PKM metabolic axis identified in recent CD8+ T-cell research.

7853 records 1/524 page Next 12345 下5页 Last page